Brief: Mayne Pharma Settles US Patent Litigation on Imvexxy With Sun Pharma
30/09/2026 02:36
BRIEF-Mayne Pharma Settles US Patent Litigation on Imvexxy With Sun Pharma Sept 30 (Reuters) - Mayne Pharma Group Ltd MYX.AX:
MYX SETTLES US PATENT LITIGATION RE IMVEXXY WITH SUN PHARMA
GENERIC IMVEXXY AGREED MARKET ENTRY DATE SET FOR 21 OCTOBER 2032
SETTLEMENT DOES NOT INCLUDE FINANCIAL PAYMENT OR UPFRONT MONETARY CONSIDERATION
Further company coverage: MYX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)